Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

THE CHEMOURS COMPANY

(CC)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Chemours : Q2 Gains Top Expectations; Guides Full-Year EPS to Top End of Prior Forecast

07/29/2021 | 04:40pm EDT


ę MT Newswires 2021
All news about THE CHEMOURS COMPANY
09/01CHEMOURS CO : Change in Directors or Principal Officers (form 8-K)
AQ
09/01CHEMOURS : Appoints Sandra Phillips Rogers to Board of Directors
PR
09/01The Chemours Company Appoints Sandra Phillips Rogers to Board of Directors
CI
08/18CHEMOURS : Closes $650 Million Senior Notes Offering
MT
08/18CHEMOURS : ANNOUNCES EARLY TENDER RESULTS OF (Form 8-K)
PU
08/18CHEMOURS CO : Entry into a Material Definitive Agreement, Creation of a Direct Financial O..
AQ
08/18THE CHEMOURS COMPANY : Announces Completion of Private Offering of $650 Million Aggregate ..
PR
08/18The Chemours Company Announces Completion of Private Offering of $650 Million Aggregate..
CI
08/17THE CHEMOURS COMPANY : Announces Early Tender Results of Conditional Cash Tender Offer and..
PR
08/17The Chemours Company Announces Early Tender Results of Conditional Cash Tender Offer an..
CI
More news
Analyst Recommendations on THE CHEMOURS COMPANY
More recommendations
Financials (USD)
Sales 2021 6 134 M - -
Net income 2021 482 M - -
Net Debt 2021 2 648 M - -
P/E ratio 2021 9,87x
Yield 2021 3,54%
Capitalization 4 628 M 4 628 M -
EV / Sales 2021 1,19x
EV / Sales 2022 1,06x
Nbr of Employees 6 500
Free-Float 85,7%
Chart THE CHEMOURS COMPANY
Duration : Period :
The Chemours Company Technical Analysis Chart | CC | US1638511089 | MarketScreener
Technical analysis trends THE CHEMOURS COMPANY
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 13
Last Close Price 28,02 $
Average target price 41,17 $
Spread / Average Target 46,9%
EPS Revisions
Managers and Directors
Mark E. Newman President, CEO, COO, Director & Senior VP
Sameer Ralhan Chief Financial Officer & Senior Vice President
Mark P. Vergnano Chairman
Randal King VP-Technology & Advanced Performance Materials
Curtis V. Anastasio Independent Director
Sector and Competitors